Laureate Education, Inc. LAUR
35.87 USD +0.38 (+1.06%)
Nov 4, 2026, 12:37 PM EST
35.48 Day range 36.30
24.98 52-week range 40.93
- YTD
- +6.52%
- 1 year
- +20.92%
Analyst view
Consensus: buy
Buy
Price target (mean) 42.07 +17.3% upside
Now 35.87
- Target (low)
- 36.50
- Target (mean)
- 42.07
- Target (high)
- 45.00
Ratings (0m) 7 5 buy · 1 hold · 1 sell
- Strong buy2
- Buy3
- Hold1
- Sell1
- Strong sell0
Recommendation trend
- This month 7
- 1 month ago 7
- 2 months ago 7
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.7763 | 0.74 – 0.84889 | 1.15 | -32.5% | 558.07M | +3.1% | 3 |
| Next quarter | -0.195 | -0.22 – -0.17 | -0.15 | -30.0% | 279.33M | +2.5% | 2 |
| Current year | 2.14 | 2.07 – 2.24 | 1.89 | +13.2% | 1.93B | +13.1% | 5 |
| Next year | 2.52 | 2.43 – 2.67 | 2.14 | +17.8% | 2.04B | +6.0% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 15, 2026 | Morgan Stanley | Maintained | Underweight | Underweight |
| Aug 3, 2026 | JP Morgan | Downgrade | Overweight | Neutral |
| Jun 4, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| May 1, 2026 | UBS | Maintained | Buy | Buy |
| Mar 26, 2026 | BMO Capital | Maintained | Outperform | Outperform |
| Mar 11, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Feb 24, 2026 | UBS | Maintained | Buy | Buy |
| Feb 23, 2026 | BMO Capital | Maintained | Outperform | Outperform |
| Feb 18, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Jan 8, 2026 | UBS | Maintained | Buy | Buy |
| Dec 10, 2025 | JP Morgan | Initiated | — | Overweight |
| Nov 3, 2025 | UBS | Maintained | Buy | Buy |
| Oct 20, 2025 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Sep 19, 2025 | UBS | Initiated | — | Buy |
| May 5, 2025 | BMO Capital | Maintained | Outperform | Outperform |
| Feb 24, 2025 | BMO Capital | Maintained | Outperform | Outperform |
| Nov 1, 2024 | BMO Capital | Maintained | Outperform | Outperform |
| Jul 26, 2024 | Morgan Stanley | Downgrade | Overweight | Equal-Weight |
| Oct 9, 2023 | Jefferies | Initiated | — | Buy |
| Oct 6, 2023 | Jefferies | Initiated | — | Buy |
| Aug 7, 2023 | Morgan Stanley | Upgrade | Equal-Weight | Overweight |
| May 8, 2023 | Morgan Stanley | Downgrade | Overweight | Equal-Weight |
| Oct 7, 2022 | Morgan Stanley | Maintained | — | Overweight |
| May 31, 2022 | Morgan Stanley | Maintained | — | Overweight |
| May 11, 2020 | BMO Capital | Maintained | — | Outperform |
| May 5, 2020 | JP Morgan | Maintained | — | Overweight |
| May 4, 2020 | Stifel | Maintained | — | Buy |
| Apr 23, 2020 | Barrington Research | Maintained | — | Outperform |
| Apr 8, 2020 | Morgan Stanley | Downgrade | Overweight | Equal-Weight |
| Jan 29, 2020 | Stifel | Maintained | — | Buy |